Muscle Function and Effects of Repetitive Task Training in Patients With Inflammatory Myopaties
Correlation of "Myositis Functional Index-3 (Fi-3)" With Muscle Function Assessed by Isokinetic Dynamometry and Effects of Repetitive Task Training in Patients With Inflammatory Myopaties
1 other identifier
interventional
2
1 country
1
Brief Summary
Idiopathic inflammatory myopathies lead to important functional limitations resulting from the loss of muscle strength and endurance, especially in the hip and shoulder, which leads to a significant loss of quality of life for patients. The aim of this study is to correlate the "Myositis Functional Index-3 (FI-3)" with muscle function assessed by computerized isokinetic dynamometry, electromyography and magnetic resonance through an observational study; and to study the effects of a repetitive task training program through an interventional study in patients with inflammatory myopathies. It is expected that FI-3 will present a good correlation with muscle function assessed by computerized isokinetic dynamometry and electromyography, given its reduced cost and less time spent on evaluation. It is also expected to demonstrate that repetitive task training is efficient and safe.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 29, 2021
CompletedFirst Posted
Study publicly available on registry
August 30, 2021
CompletedStudy Start
First participant enrolled
September 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2023
CompletedMarch 23, 2026
March 1, 2026
1 year
July 29, 2021
March 19, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
muscle performance endurance
"Myositis Functional Index-3 (FI-3)"; number of repetition of each muscle group task from 0-60
2 years
computerized muscle endurance test
"isokinetic dynamometry"; number of repetitions of shoulder and hip flexion until exhaustion
2 years
Secondary Outcomes (13)
manual muscle strength test
2 years
computerized muscle strength test
2 years
cardiopulmonary capacity
2 years
functional capacity
2 years
quality of life level
2 years
- +8 more secondary outcomes
Study Arms (1)
repetitive task training
EXPERIMENTALThe repetitive task training group will carry out exercises involving upper and lower limbs.
Interventions
The repetitive task training group will carry out exercises involving upper and lower limbs.
Eligibility Criteria
You may qualify if:
- diagnosis of polymyositis or dermatomyositis (Bohan and Peter criteria)
- age ≥18 years
- duration of disease since diagnosis for more than six months
- stable medication ≥3 months
- chronic inactive or mildly active but stable myositis for at least 3 months prior to observation
- Health Assessment Questionnaire (HAQ) ≥0.5
You may not qualify if:
- serious cardiac or pulmonary conditions
- severe osteoporosis
- unable to exercise
- neoplasm
- cognitive disorders
- acute or chronic infection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Samira Tatiyama Miyamoto, PhD
Vitória, Espírito Santo, 29050-780, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
July 29, 2021
First Posted
August 30, 2021
Study Start
September 1, 2021
Primary Completion
September 1, 2022
Study Completion
September 1, 2023
Last Updated
March 23, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share